Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab

Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab

The Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab is a premier diagnostic tool used to evaluate a woman’s ovarian reserve and overall reproductive health. Anti-Mullerian Hormone (AMH) is a glycoprotein hormone belonging to the transforming growth factor-beta superfamily. In females, AMH is secreted exclusively by the granulosa cells of preantral and small antral follicles in the ovaries. Because its production is directly linked to the growing pool of early-stage follicles, serum AMH levels serve as a highly reliable surrogate marker for the quantitative aspect of the ovarian reserve. Unlike other reproductive hormones such as Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Estradiol, which exhibit significant fluctuations throughout the menstrual cycle, AMH levels remain relatively stable. This stability allows the blood sample to be collected at any point during the menstrual cycle, offering unparalleled convenience and clinical utility for both patients and clinicians.

At Dr. Essa Laboratory and Diagnostic Centre, we utilize state-of-the-art automated immunoassay platforms to measure serum AMH concentrations with extreme precision. This test is of paramount importance in modern reproductive medicine, particularly in the planning and management of assisted reproductive technologies (ART) such as In Vitro Fertilization (IVF). By determining the ovarian reserve, reproductive endocrinologists can predict a patient’s response to controlled ovarian hyperstimulation, customize gonadotropin dosages to optimize oocyte yield, and minimize the risk of life-threatening complications like Ovarian Hyperstimulation Syndrome (OHSS). Beyond fertility assessments, the Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab plays a critical role in diagnosing endocrine disorders such as Polycystic Ovary Syndrome (PCOS), evaluating cases of premature ovarian insufficiency (POI), predicting the onset of menopause, and monitoring patients undergoing treatment for specific ovarian malignancies, such as granulosa cell tumors.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab is straightforward, as the test does not require complex interventions. However, adhering to specific clinical guidelines ensures the highest level of diagnostic accuracy:

• No Fasting Required: Patients do not need to fast before the blood draw. You may consume food and drinks normally.
• Menstrual Cycle Timing: The test can be performed on any day of your menstrual cycle, as serum AMH levels do not fluctuate significantly.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff about all medications you are currently taking. Oral contraceptive pills, hormone replacement therapy (HRT), and biotin supplements can potentially interfere with hormone measurements.
• Biotin Avoidance: If you are taking high-dose biotin supplements (often found in hair, skin, and nail formulas), it is recommended to discontinue them at least 72 hours prior to the test, as biotin can interfere with streptavidin-biotin-based immunoassay methodologies.
• Hydration: Ensure you are well-hydrated before the procedure, as this makes venipuncture easier and more comfortable.

During the Procedure

The collection of the serum sample for the AMH test is a standard venipuncture procedure executed by our highly trained phlebotomists at Dr. Essa Lab:

• Patient Positioning: You will be asked to sit comfortably in a phlebotomy chair. The phlebotomist will examine your arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow).
• Aseptic Technique: The selected area is thoroughly cleansed with an antiseptic swab (usually 70% isopropyl alcohol) to prevent infection and ensure sample sterility.
• Sample Collection: A sterile, single-use needle is gently inserted into the vein. A vacuum collection tube (typically a serum separator tube or SST with a gold or red top) is attached to collect the required volume of blood (usually 3 to 5 mL).
• Pressure and Bandaging: Once the sample is collected, the needle is carefully withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton ball or gauze to promote hemostasis. A small adhesive bandage is then applied.
• Safety and Comfort: The entire process takes less than five minutes. Our staff prioritizes patient comfort, ensuring minimal discomfort during the needle insertion. All materials used are strictly sterile and disposed of according to biohazard safety protocols.

When is an Anti Mullerian Hormone Test (AMH) – (Serum) Performed?

Assessment of Ovarian Reserve and Fertility Potential

Physicians frequently request the Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab for women who are planning to conceive, particularly those of advanced maternal age (35 years and older) or those who have been experiencing unexplained infertility. As women age, the quantity and quality of their remaining oocytes naturally decline. By measuring serum AMH levels, clinicians can estimate the remaining primordial follicle pool. This information is vital for counseling patients on their natural fertility window, determining the urgency of conception efforts, or deciding whether to pursue fertility preservation options such as oocyte or embryo cryopreservation.

Evaluation of Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome is a highly prevalent endocrine disorder characterized by ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology on ultrasound. Women with PCOS typically exhibit a significantly increased number of preantral and small antral follicles, which leads to abnormally elevated serum AMH concentrations. Physicians utilize the AMH test at Dr. Essa Lab to support the diagnosis of PCOS, especially in cases where ultrasound findings are inconclusive or difficult to obtain. Monitoring AMH levels also helps assess the severity of the syndrome and track the effectiveness of therapeutic interventions.

Investigation of Premature Ovarian Insufficiency (POI)

Premature Ovarian Insufficiency, also known as premature ovarian failure, refers to the loss of normal ovarian function before the age of 40. Patients with POI often present with symptoms such as irregular periods, amenorrhea, hot flashes, and vaginal dryness. A low or undetectable serum AMH level, when combined with elevated FSH levels, helps confirm a diagnosis of POI. Identifying this condition early allows healthcare providers to initiate appropriate hormone replacement therapy (HRT) to protect bone and cardiovascular health and discuss alternative family planning strategies.

Monitoring Ovarian Cancer Treatment

Certain types of ovarian cancers, specifically granulosa cell tumors, secrete high amounts of Anti-Mullerian Hormone. For patients diagnosed with these specific neoplasms, the Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab serves as an invaluable tumor marker. Clinicians order serial AMH tests before surgery to establish a baseline, and subsequently during post-treatment follow-up. A rising AMH level after therapeutic intervention can be an early indicator of tumor recurrence or metastasis, allowing for prompt clinical action.

Assessment of Infants with Ambiguous Genitalia or Cryptorchidism

In pediatric endocrinology, the AMH test is highly useful for evaluating infants with ambiguous genitalia or undescended testicles (cryptorchidism). In male fetuses, AMH is produced by the Sertoli cells of the testes and is responsible for the regression of the Mullerian ducts (which would otherwise develop into female reproductive organs). Measuring serum AMH levels helps clinicians determine the presence or absence of functional testicular tissue in male infants, aiding in the accurate diagnosis of disorders of sex development (DSD) and guiding surgical and medical management.

What Does an Anti Mullerian Hormone Test (AMH) – (Serum) Detect?

The Anti Mullerian Hormone Test (AMH) – (Serum) at Dr. Essa Lab is capable of detecting and indicating a wide range of clinical conditions and physiological states related to reproductive health:

• Diminished Ovarian Reserve (DOR): Low levels of AMH indicate a reduced pool of remaining eggs, suggesting a shorter reproductive window.
• Age-Appropriate Ovarian Reserve: Confirms whether a woman’s egg count aligns with clinical expectations for her specific age group.
• Polycystic Ovary Syndrome (PCOS) Indicators: Markedly elevated AMH levels strongly point toward the presence of PCOS.
• Ovarian Response in IVF: Predicts whether a patient will be a poor responder, normal responder, or hyper-responder to gonadotropin stimulation.
• Risk of Ovarian Hyperstimulation Syndrome (OHSS): High AMH levels alert clinicians to a high risk of OHSS, allowing for protocol adjustments.
• Onset of Menopause: Extremely low or undetectable AMH levels help predict the transition into menopause.
• Premature Ovarian Insufficiency (POI): Detects early ovarian failure in women under the age of 40.
• Presence of Functional Testicular Tissue: In pediatric cases, confirms the presence of active Sertoli cells in infants with cryptorchidism.
• Granulosa Cell Tumor Recurrence: Serves as a sensitive monitoring tool for detecting the return of specific ovarian cancers.
• Anovulatory Infertility: Assists in identifying hormonal imbalances responsible for lack of ovulation.
• Hypogonadotropic Hypogonadism: Helps differentiate between various causes of secondary amenorrhea.
• Ovarian Damage from Chemotherapy: Assesses the impact of gonadotoxic cancer treatments on a woman’s fertility.
• Ovarian Damage from Radiation: Evaluates pelvic radiation-induced reduction in ovarian reserve.
• Surgical Impact on Ovaries: Measures the loss of ovarian tissue following surgeries like cystectomy or oophorectomy.
• Persistent Mullerian Duct Syndrome (PMDS): Detects genetic mutations in males where AMH or its receptors are non-functional.
• Congenital Anorchia: Confirms the complete absence of testicular tissue in male infants.
• Ovarian Aging Rate: Helps track the rate of decline in ovarian reserve over time through serial testing.
• Efficacy of PCOS Management: Monitors changes in ovarian activity following lifestyle or medical treatments for PCOS.
• Incipient Ovarian Failure: Identifies early-stage decline in ovarian function before FSH levels begin to rise.
• Success of Ovarian Tissue Transplantation: Evaluates the functional recovery of grafted ovarian tissue.
• Fertility Potential Post-Endometriosis Surgery: Assesses remaining ovarian capacity after excision of endometriomas.
• Asymptomatic Ovarian Dysfunction: Identifies subclinical reproductive hormonal imbalances during routine fertility checkups.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for diagnostic results can be an anxious time for patients and their families. We utilize fully automated, high-throughput immunoassay systems to process the Anti Mullerian Hormone Test (AMH) – (Serum) with maximum efficiency and accuracy. Typically, the test results are finalized and verified by our consultant pathologists within 24 to 48 hours of sample collection. Once the report is ready, patients receive an automated SMS notification containing a direct link to download their digital report. Reports can also be accessed securely through the official Dr. Essa Lab website or mobile application by entering the patient’s lab ID and password. For those who prefer physical copies, reports can be collected from any of our conveniently located diagnostic centers across Karachi and other major cities.

Anti Mullerian Hormone Test (AMH) – (Serum) Findings Overview

The following table provides a general clinical guide to interpreting serum AMH levels across different patient demographics and clinical scenarios:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Ovarian Reserve (Age < 30)	2.0 to 6.8 ng/mL (Optimal fertility potential)	< 1.0 ng/mL (Diminished reserve); > 6.8 ng/mL (Suspected PCOS)
Ovarian Reserve (Age 30–35)	1.5 to 4.0 ng/mL (Good fertility potential)	< 0.8 ng/mL (Low reserve for age); > 5.0 ng/mL (Possible PCOS)
Ovarian Reserve (Age 35–40)	1.0 to 2.5 ng/mL (Satisfactory reserve)	< 0.5 ng/mL (Significantly diminished reserve)
Ovarian Reserve (Age > 40)	0.3 to 1.0 ng/mL (Expected age-related decline)	< 0.1 ng/mL (Severely depleted reserve / near menopause)
Polycystic Ovary Syndrome (PCOS)	< 5.0 ng/mL (Non-PCOS range)	> 6.8 ng/mL (Highly suggestive of PCOS pathology)
Menopause Transition	< 0.1 ng/mL (Undetectable, confirming menopause)	> 0.5 ng/mL in suspected postmenopausal state (requires re-evaluation)
Pediatric Male (Infants)	High levels (indicating active Sertoli cell function)	Undetectable levels (suggests anorchia or testicular failure)
Ovarian Tumor Marker (Granulosa Cell)	Undetectable or normal age-matched female range	Markedly elevated levels (indicates primary tumor or recurrence)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Anti Mullerian Hormone Test (AMH) – (Serum)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists and clinical chemists who oversee all testing procedures.
• Patient-Focused Care: We prioritize patient comfort, privacy, and clear communication throughout the diagnostic journey.
• Quality Diagnostic Services: Dr. Essa Lab utilizes advanced, fully automated immunoassay analyzers to deliver highly precise and reproducible results.
• Professional Reporting: All reports undergo rigorous multi-level verification to ensure absolute clinical accuracy.
• Modern Diagnostic Approach: We continuously update our laboratory technologies and methodologies in line with international standards.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, safe, and welcoming atmosphere for all patients.
• Convenient Location: With an extensive network of collection centers across Karachi and other cities, finding a location near you is simple.
• Commitment to Accurate Diagnosis: Since 1987, Dr. Essa Lab has remained dedicated to supporting clinical decisions with trustworthy diagnostic insights.